Gastrointestinal Manifestations of Connective Tissue Diseases: Diagnosis, Treatment, and Emerging Research

Moderator(s)

• 

  Silvia Bellando-Randone, MD, PhD

  University of Florence
  Florence, Florence, Italy

  Disclosure(s): No financial relationships with ineligible companies to disclose
• SG

  Samuel Good, MD

  David Geffen School of Medicine at University of California, Los Angeles, Department of Medicine, Division of Rheumatology
  Los Angeles, CA, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Session Coordinator(s)

• 

  Elizabeth Volkmann, MD, MS

  Associate Professor, Division of Rheumatology
  University of California, Los Angeles
  Los Angeles, California, United States

  Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Atyr Pharma: Grant/Research Support (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Horizon: Grant/Research Support (Ongoing); Kadmon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
• 

  DeAnna Baker Frost, MD;PhD

  Assistant Professor
  Medical University of South Carolina
  Charleston, SC, United States

  Disclosure(s): Allogene: Consultant (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing)

This session will review both clinical and translational aspects of gastrointestinal (GI) tract involvement in autoimmune rheumatic diseases. This multi-disciplinary session will feature the perspective of an expert gastroenterologist who review the diverse GI manifestations of autoimmune rheumatic diseases and guide the rheumatologist on how to diagnose these conditions and work collaboratively with gastroenterology. This session will also review the role of the gut microbiome in GI involvement, focusing on two novel areas: Using the gut microbiome to inform treatment decisions in rheumatoid arthritis and modifying the gut microbiome with nutritional approaches that may alleviate GI symptoms.

Presentations:

• 8:30 AM - 9:00 AM Central Time

  The Impact of the Gut Microbiome in Individuals at Risk of Rheumatoid Arthritis
  

  Speaker: Christopher Rooney, MD, PhD, MRCP – University of Leeds, UK
• 9:00 AM - 9:30 AM Central Time

  Gastrointestinal Disease in Rheumatoid Arthritis: The Impact of the Gut Microbiome on Treatment
  

  Speaker: Renuka Nayak, MD, PhD – University of California, San Francisco (UCSF)
• 9:30 AM - 10:00 AM Central Time

  Nutrition and the Gut Microbiome: Dietary Modifications That May Ameliorate Gastrointestinal Symptoms in Autoimmune Rheumatic Diseases
  

  Speaker: Elizabeth Volkmann, MD, MS – University of California, Los Angeles